CNS Pharmaceuticals, Inc. (CNSP)

NASDAQ: CNSP · IEX Real-Time Price · USD

0.204

-0.010 (-4.67%)

At close: Apr 25, 2024, 3:58 PM

0.215

+0.011 (5.20%)

After-hours: Apr 25, 2024, 6:24 PM EDT

CNS Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	4.77	5.97	4.68	4.39	1.98	0.86
Research & Development	14.1	9.3	9.81	5.06	1.85	0.02
Operating Expenses	18.87	15.27	14.49	9.45	3.83	0.88
Operating Income	-18.87	-15.27	-14.49	-9.45	-3.83	-0.88
Interest Expense / Income	0.01	0.01	0.01	0	0.03	0.03
Other Expense / Income	-0.03	-	-	-	0.02	6.48
Pretax Income	-18.85	-15.27	-14.5	-9.46	-3.88	-7.39
Net Income	-18.85	-15.27	-14.5	-9.46	-3.88	-7.39
Shares Outstanding (Basic)	4	1	1	1	0	0
Shares Outstanding (Diluted)	4	1	1	1	0	0
Shares Change	176.66%	55.02%	58.58%	21.77%	29.85%	-
EPS (Basic)	-5.00	-11.22	-16.50	-17.10	-8.40	-21.00
EPS (Diluted)	-5.00	-11.22	-16.50	-17.10	-8.40	-21.00
Free Cash Flow	-14.14	-10.56	-13.54	-7.34	-3.57	-0.72
Free Cash Flow Per Share	-3.75	-7.76	-15.42	-13.24	-7.86	-2.04
EBITDA	-18.83	-15.26	-14.47	-9.44	-3.85	-7.36
Depreciation & Amortization	0	0.01	0.01	0.01	0	0
EBIT	-18.84	-15.27	-14.49	-9.45	-3.85	-7.36

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).